Show simple item record

dc.contributor.authorFeng, Guoping
dc.contributor.authorTing, Jonathan Thomas
dc.date.accessioned2016-05-05T00:16:36Z
dc.date.available2016-05-05T00:16:36Z
dc.date.issued2013-03
dc.date.submitted2013-02
dc.identifier.issn01664328
dc.identifier.urihttp://hdl.handle.net/1721.1/102413
dc.description.abstractHere we review the rapidly growing toolbox of transgenic mice and rats that exhibit functional expression of engineered opsins for neuronal activation and silencing with light. Collectively, these transgenic animals are enabling neuroscientists to access and manipulate the many diverse cell types in the mammalian nervous system in order to probe synaptic and circuitry connectivity, function, and dysfunction. The availability of transgenic lines affords important advantages such as stable and heritable transgene expression patterns across experimental cohorts. As such, the use of transgenic lines precludes the need for other costly and labor-intensive procedures to achieve functional transgene expression in each individual experimental animal. This represents an important consideration when large cohorts of experimental animals are desirable as in many common behavioral assays. We describe the diverse strategies that have been implemented for developing transgenic mouse and rat lines and highlight recent advances that have led to dramatic improvements in achieving functional transgene expression of engineered opsins. Furthermore, we discuss considerations and caveats associated with implementing recently developed transgenic lines for optogenetics-based experimentation. Lastly, we propose strategies that can be implemented to develop and refine the next generation of genetically modified animals for behaviorally-focused optogenetics-based applications.en_US
dc.description.sponsorshipPoitras Center for Affective Disorders Researchen_US
dc.description.sponsorshipNational Institute of Mental Health (U.S.) (American Recovery and Reinvestment Act Grant RC1-MH088434)en_US
dc.description.sponsorshipNational Alliance for Research on Schizophrenia and Depression. The Brain and Behavior Research Foundation (Young Investigator Award)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Ruth L. Kirschstein National Research Service Award F32MH084460)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.bbr.2013.02.037en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleDevelopment of transgenic animals for optogenetic manipulation of mammalian nervous system function: Progress and prospects for behavioral neuroscienceen_US
dc.typeArticleen_US
dc.identifier.citationTing, Jonathan T., and Guoping Feng. “Development of Transgenic Animals for Optogenetic Manipulation of Mammalian Nervous System Function: Progress and Prospects for Behavioral Neuroscience.” Behavioural Brain Research 255 (October 2013): 3–18.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.mitauthorTing, Jonathan Thomasen_US
dc.contributor.mitauthorFeng, Guopingen_US
dc.relation.journalBehavioural Brain Researchen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsTing, Jonathan T.; Feng, Guopingen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-8021-277X
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record